.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Queensland Health
Baxter
Farmers Insurance
Harvard Business School
Medtronic
Johnson and Johnson
Citi
Fish and Richardson
Cerilliant

Generated: June 26, 2017

DrugPatentWatch Database Preview

SULFASALAZINE Drug Profile

« Back to Dashboard

What is the patent landscape for Sulfasalazine, and what generic Sulfasalazine alternatives are available?

Sulfasalazine is a drug marketed by Watson Labs, Vintage Pharms, Superpharm, Sandoz, Sun Pharm Inds, and Heritage Pharms Inc. and is included in ten NDAs.

The generic ingredient in SULFASALAZINE is sulfasalazine. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

Summary for Tradename: SULFASALAZINE

Patents:0
Applicants:6
NDAs:10
Suppliers / Packagers: see list9
Bulk Api Vendors: see list77
Clinical Trials: see list58
Patent Applications: see list8,095
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SULFASALAZINE at DailyMed

Pharmacology for Tradename: SULFASALAZINE

Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
SULFASALAZINE
sulfasalazine
TABLET;ORAL085828-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe
Sandoz
SULFASALAZINE
sulfasalazine
TABLET;ORAL086184-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Vintage Pharms
SULFASALAZINE
sulfasalazine
TABLET;ORAL040349-001Jan 11, 2002ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds
SULFASALAZINE
sulfasalazine
TABLET;ORAL089590-001Oct 19, 1987DISCNNoNo► Subscribe► Subscribe
Vintage Pharms
SULFASALAZINE
sulfasalazine
TABLET, DELAYED RELEASE;ORAL075339-001Jan 11, 2002ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Teva
McKesson
Johnson and Johnson
Baxter
AstraZeneca
Cerilliant
Cipla
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot